All In MedTech

FDA Clearance Tracker · P080006-S137

MEDTRONIC ATTAIN ABILITY MODEL 4196 LEAD

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Apr 23, 2020 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P080006-S137
Device name
MEDTRONIC ATTAIN ABILITY MODEL 4196 LEAD
Applicant location
Minneapolis, MN
Received
Jul 1, 2019
Decided
Apr 23, 2020
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P080006

Device type

Device class
Class III

Every decision under product code OJX

FDA's approval statement

As written in FDA's record.

Approval for Cobalt XT, Cobalt, and Crome MRI SureScan Implantable Cardioverter Defibrillator (ICD) and ICD with Cardiac Resynchronization Systems.

Source documents

Other decisions for Medtronic, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.